Literature DB >> 11703471

Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire.

R B Lipton1, W F Stewart, J Sawyer, J G Edmeads.   

Abstract

OBJECTIVE: We evaluated the agreement between Migraine Disability Assessment (MIDAS) scores and independent physician judgments about pain, disability, and treatment needs based on patient medical histories.
BACKGROUND: The MIDAS questionnaire measures headache-related disability as lost time due to headache from paid work or school, household work, and nonwork activities.
METHODS: Twelve histories from patients with migraine were presented to 49 primary and specialty care physicians unaware of the MIDAS scores. Physicians graded each patient for pain level (mild, moderate, or severe), level of disability (none, mild, moderate, or severe), and need for medical care (from 0 [lowest] to 100 [highest]). Physicians also identified MIDAS scores they associated with different degrees of disability and with the urgency to prescribe an effective treatment during the first consultation.
RESULTS: The physicians' perceptions of the need for medical care based on medical histories correlated with the MIDAS score (r =.69). Estimates of pain and disability by physicians were directly correlated with increasing MIDAS scores. Using the physicians' clinical judgments, the overall MIDAS score was categorized into four grades of increasing severity.
CONCLUSIONS: Scores on the MIDAS are highly correlated with physician judgments regarding patients' pain, disability, and need for medical care. These findings support the potential utility of the MIDAS questionnaire in clinical practice.

Entities:  

Mesh:

Year:  2001        PMID: 11703471

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  63 in total

1.  Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction.

Authors:  Peter B Cotton; Valerie Durkalski; Kyle B Orrell; Olga Brawman-Mintzer; Douglas A Drossman; C Mel Wilcox; Patrick D Mauldin; Grace H Elta; Paul R Tarnasky; Evan L Fogel; Sanjay B Jagganath; Richard A Kozarek; Martin L Freeman; Joseph Romagnuolo; Patricia R Robuck
Journal:  Gastrointest Endosc       Date:  2010-11       Impact factor: 9.427

2.  Development of a measure of self-efficacy for acute headache medication adherence.

Authors:  Elizabeth K Seng; Robert A Nicholson; Kenneth A Holroyd
Journal:  J Behav Med       Date:  2015-09-24

3.  Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine.

Authors:  Bekir Enes Demiryurek; Devrimsel Harika Ertem; Atilla Tekin; Mustafa Ceylan; Yesim Guzey Aras; Belma Dogan Gungen
Journal:  Neurol Sci       Date:  2016-07-14       Impact factor: 3.307

Review 4.  Calcitonin gene-related peptide: A molecular link between obesity and migraine?

Authors:  Ana Recober; Peter J Goadsby
Journal:  Drug News Perspect       Date:  2010-03

5.  Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.

Authors:  Matilde Leonardi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

6.  Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.

Authors:  Virginia L Stauffer; David W Dodick; Qi Zhang; Jeffrey N Carter; Jessica Ailani; Robert R Conley
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

Review 7.  The Face of Chronic Migraine Which Has Started to be Clarified.

Authors:  Zeynep Aydin Özemir; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

8.  The medical care utilization and costs associated with migraine headache.

Authors:  Jennifer Elston Lafata; Christina Moon; Carol Leotta; Ken Kolodner; Laila Poisson; Richard B Lipton
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

Review 9.  Migraine and functional impairment.

Authors:  Jan Lewis Brandes
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

Review 10.  Classification of pediatric headache.

Authors:  Paul Winner
Journal:  Curr Pain Headache Rep       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.